Corvus Pharmaceuticals
CRVS
$1.58
Share price
8.97%
Change (1 day)
42.34%
Change (1 year)
Categories
Earnings for Corvus Pharmaceuticals (CRVS)
Earnings in 2023 (TTM): -$27.03 M
According to Corvus Pharmaceuticals 's latest financial reports the company's current earnings (TTM) are -$27.03 M. In 2022 the company made an earning of -$41.31 M an increase over its 2021 earnings that were of -$43.25 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Corvus Pharmaceuticals from 2015 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$27.03 M | -34.57% |
| 2022 | -$41.31 M | -4.47% |
| 2021 | -$43.25 M | 621.28% |
| 2020 | -$6 M | -87.16% |
| 2019 | -$46.68 M | -0.57% |
| 2018 | -$46.94 M | -15.67% |
| 2017 | -$55.67 M | 53.03% |
| 2016 | -$36.38 M | 16.08% |
| 2015 | -$31.34 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | 309.86% | 🇺🇸 USA |